Paper39475618
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments.
Kennedy PR and 22 others. Sci Adv, 2024. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments. Papers, record 39475618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39475618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Tumor Microenvironment | Major topic |
| Interleukin-15 | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Cytotoxicity, Immunologic | |
| Cell Line, Tumor | |
| Signal Transduction | |
| Cell Hypoxia |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 CA283892 | NCI NIH HHS | United States | R35CA283892 | PubMed and NIH | NIH RePORTER |
| P30 CA077598 | NCI NIH HHS | United States | P30CA077598 | PubMed and NIH | NIH RePORTER |
| R37 AI034495 | NIAID NIH HHS | United States | R37AI034495 | PubMed and NIH | NIH RePORTER |
| T35 AI118620 | NIAID NIH HHS | United States | T35AI118620 | PubMed | NIH RePORTER |
| P01 CA111412 | NCI NIH HHS | United States | P01CA111412 | PubMed and NIH | NIH RePORTER |
| P01 HL158505 | NHLBI NIH HHS | United States | P01HL158505 | PubMed and NIH | NIH RePORTER |
| R01 AG069781 | NIA NIH HHS | United States | R01AG069781 | PubMed and NIH | NIH RePORTER |
| R01 DK091538 | NIDDK NIH HHS | United States | R01DK091538 | PubMed and NIH | NIH RePORTER |
| T32GM133393 | NIH | NIH RePORTER |
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27655849 | Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27655849 | PubMed |
| 2 | 27118044 | Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia? | Exp Hematol | 2016 | https://conductscience.org/library/papers/27118044 | PubMed |
| 3 | 13130303 | Targeting HIF-1 for cancer therapy. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/13130303 | PubMed |
| 4 | 24043259 | High interstitial fluid pressure promotes tumor cell proliferation and invasion in oral squamous cell carcinoma. | Int J Mol Med | 2013 | https://conductscience.org/library/papers/24043259 | PubMed |
| 5 | 34257622 | Hypoxia Signaling in Cancer: From Basics to Clinical Practice. | Pathol Oncol Res | 2021 | https://conductscience.org/library/papers/34257622 | PubMed |
| 6 | 26873994 | Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells. | J Immunol | 2016 | https://conductscience.org/library/papers/26873994 | PubMed |
| 7 | 30938977 | Targeted Determination of Tissue Energy Status by LC-MS/MS. | Anal Chem | 2019 | https://conductscience.org/library/papers/30938977 | PubMed |
| 8 | 18855142 | The mechanical environment of bone marrow: a review. | Ann Biomed Eng | 2008 | https://conductscience.org/library/papers/18855142 | PubMed |
| 9 | 32695845 | Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/32695845 | PubMed |
| 10 | 38892084 | Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892084 | PubMed |
| 11 | 17536958 | Detection and characterization of tumor hypoxia using pO2 histography. | Antioxid Redox Signal | 2007 | https://conductscience.org/library/papers/17536958 | PubMed |
| 12 | 12160140 | Change of oxygen pressure in glioblastoma tissue under various conditions. | J Neurooncol | 2002 | https://conductscience.org/library/papers/12160140 | PubMed |
| 13 | 31477722 | Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. | Nat Commun | 2019 | https://conductscience.org/library/papers/31477722 | PubMed |
| 14 | 34077737 | Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function. | Cell Rep | 2021 | https://conductscience.org/library/papers/34077737 | PubMed |
| 15 | 27129235 | Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27129235 | PubMed |
| 16 | 33782423 | STAT3 governs the HIF-1α response in IL-15 primed human NK cells. | Sci Rep | 2021 | https://conductscience.org/library/papers/33782423 | PubMed |
| 17 | 22279576 | Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22279576 | PubMed |
| 18 | 33431318 | Generating natural killer cells for adoptive transfer: expanding horizons. | Cytotherapy | 2021 | https://conductscience.org/library/papers/33431318 | PubMed |
| 19 | 34138753 | Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34138753 | PubMed |
| 20 | 31624330 | Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells. | Sci Rep | 2019 | https://conductscience.org/library/papers/31624330 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909080 | Trifunctional antibody fusion proteins for targeted co-delivery of 4-1BBL with IL-15 or IL-21 to enhance antitumor immune responses. | Front Immunol | 2026 | https://conductscience.org/library/papers/42909080 | PubMed |
| 42807291 | Immunosuppressive tumor microenvironment and immunotherapy resistance of esophageal carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807291 | PubMed |
| 42769371 | Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42769371 | PubMed |
| 42756298 | Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42756298 | PubMed |
| 42713156 | Decoding the tumor microenvironment of triple-negative breast cancer: from immune evasion to precision immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42713156 | PubMed |
| 42540267 | The Potential of AI-Driven High-Content Imaging in Drug Discovery. | ACS Omega | 2026 | https://conductscience.org/library/papers/42540267 | PubMed |
| 42510713 | Natural Killer Cell Immunotherapy in Solid Tumors: Microenvironmental Obstacles and Translational 3D Models. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510713 | PubMed |
| 42346099 | The Architecture of Immune Escape in Neuroblastoma: Plasticity, Silence and Escape Engineer Immune Blindness. | Cells | 2026 | https://conductscience.org/library/papers/42346099 | PubMed |
| 42273671 | Bridging aging and colorectal cancer: synergistic roles of inflammaging and immunosenescence. | Front Immunol | 2026 | https://conductscience.org/library/papers/42273671 | PubMed |
| 42242227 | HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42242227 | PubMed |
| 42233035 | Tumor immune microenvironment in non-small cell lung cancer progression. | Front Immunol | 2026 | https://conductscience.org/library/papers/42233035 | PubMed |
| 42079032 | Hypoxic tumor microenvironment and immune cell dynamics: From metabolic reprogramming to therapeutic innovation. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42079032 | PubMed |
| 42033573 | Progress in cell-based immunotherapies for solid tumors. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42033573 | PubMed |
| 42006290 | Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia. | iScience | 2026 | https://conductscience.org/library/papers/42006290 | PubMed |
| 41925950 | Mapping research trends in immune cell metabolic reprogramming in breast cancer: a parallel dual-database bibliometric study. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41925950 | PubMed |
| 41764546 | Targeting metabolic reprogramming to enhance adoptive immunotherapy: emerging mechanisms and translational perspectives. | J Transl Med | 2026 | https://conductscience.org/library/papers/41764546 | PubMed |
| 41744817 | Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors. | Cells | 2026 | https://conductscience.org/library/papers/41744817 | PubMed |
| 41706678 | DRP1 depletion protects NK cells from hypoxia-induced dysfunction. | Redox Rep | 2026 | https://conductscience.org/library/papers/41706678 | PubMed |
| 41511303 | CAR-NK Engineering to Overcome TME Barriers. | Cells | 2025 | https://conductscience.org/library/papers/41511303 | PubMed |
| 41463052 | Lactate-Mediated Epigenetic and Immunometabolic Reprogramming in Glioma: An Emerging Axis Linking Metabolism to Tumor Progression. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463052 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD2 | 914 | PubTator's text mining | https://conductscience.org/library/genes/914 | NCBI Gene |
| EOMES | 8320 | PubTator's text mining | https://conductscience.org/library/genes/8320 | NCBI Gene |
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
| FCGR3A | 2214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| IL15 | 3600 | PubTator's text mining | https://conductscience.org/library/genes/3600 | NCBI Gene |
| IL21 | 59067 | PubTator's text mining | https://conductscience.org/library/genes/59067 | NCBI Gene |
| IL2RB | 3560 | PubTator's text mining | https://conductscience.org/library/genes/3560 | NCBI Gene |
| TBX21 | 30009 | PubTator's text mining | https://conductscience.org/library/genes/30009 | NCBI Gene |
| TNFSF10 | 8743 | PubTator's text mining | https://conductscience.org/library/genes/8743 | NCBI Gene |
| TNFSF9 | 8744 | PubTator's text mining | https://conductscience.org/library/genes/8744 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39475618
GET https://conductscience.org/api/papers/v1/39475618/authors?page=2